Results 11 to 20 of about 2,386 (174)

Case Report: Compound heterozygous familial hypercholesterolemia in a pediatric patient with multiple cutaneous xanthomas [PDF]

Frontiers in Pediatrics
Familial hypercholesterolemia (FH) is an inherited disorder of lipid metabolism characterized by markedly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels, formation of xanthomas, and early-onset atherosclerotic cardiovascular disease ...
Qian Yang, Lihong Jiang, Xinyi Wei, Xinyang Lv, Yue Zhao, Geli Liu   +5 more
doaj   +2 more sources

Low‐density lipoprotein apheresis is associated with removal of SARS‐CoV‐2 antibodies [PDF]

Therapeutic Apheresis and Dialysis, 2022
Sebastian Bertram, Maximilian Seidel, Bodo Holzer   +2 more
exaly   +2 more sources

Mechanism, clinical consequences, and management of dyslipidemia in children with nephrotic syndrome [PDF]

Childhood Kidney Diseases, 2022
Dyslipidemia in nephrotic syndrome (NS) is often characterized by marked increases in the levels of total cholesterol, triglycerides, low-density lipoprotein cholesterol, and other lipoproteins, such as very low-density lipoprotein, intermediate-density ...
Hee Sun Baek
doaj   +1 more source

Therapeutic apheresis in kidney diseases: an updated review

Renal Failure, 2022
Besides conventional medical therapies, therapeutic apheresis has become an important adjunctive or alternative therapeutic option to immunosuppressive agents for primary or secondary kidney diseases and kidney transplantation.
Yi-Yuan Chen, Xin Sun, Wei Huang, Fang-Fang He, Chun Zhang   +4 more
doaj   +1 more source

Role of lipoprotein apheresis in the management of familial hypercholesterolemia

Global Journal of Transfusion Medicine, 2021
Familial Hypercholesterolemia (FH) is an autosomal dominant disorder due to a congenital absence of low-density lipoprotein receptor (LDL-R) that transports cholesterol-carrying lipoprotein particles into cells.
Shamanna Seshadri Iyengar, Ambuja Kantharaj, Chandrashekar Shivaram, D S Hemantha Kumara, Roopa Murgod, G Shreedhara   +5 more
doaj   +1 more source

Pollens derived magnetic porous particles for adsorption of low-density lipoprotein from plasma

Bioactive Materials, 2021
Adsorption of low-density lipoprotein from plasma is vital for the treatment of dyslipidemia. Appropriate adsorbent material for efficient and selective adsorption of low-density lipoprotein is highly desired.
Yuetong Wang, Lingyu Sun, Jiahui Guo, Keqing Shi, Luoran Shang, Jian Xiao, Yuanjin Zhao   +6 more
doaj   +1 more source

Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia

Journal of Lipid Research, 1997
Apheresis only partially controls raised low density lipoprotein cholesterol levels in patients with homozygous familial hypercholesterolemia, who usually respond poorly to lipid-lowering drugs.
A D Marais, R P Naoumova, J C Firth, C Penny, C K Neuwirth, G R Thompson   +5 more
doaj   +1 more source

Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein B

Journal of Lipid Research, 2000
Apheresis is a treatment option for patients with severe hypercholesterolemia and coronary artery disease. It is unknown whether such therapy changes kinetic parameters of lipoprotein metabolism, such as apolipoprotein B (apoB) secretion rates ...
Klaus G. Parhofer, P. Hugh R. Barrett, Thomas Demant, Peter Schwandt   +3 more
doaj   +1 more source

Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report

Journal of Medical Case Reports, 2009
Introduction Lipoprotein glomerulopathy is a glomerulonephritis which was described for the first time by Saito in 1989 and is currently acknowledged as a separate nosological entity.
Rivasi Paolo, Romano Nicola, Magistroni Riccardo, Leonelli Marco, Furci Luciana, Russi Gianpaolo, Albertazzi Alberto   +6 more
doaj   +1 more source

Case report: Therapy adherence, MTTP variants, and course of atheroma in two patients with HoFH on low-dose, long-term lomitapide therapy

Frontiers in Genetics, 2023
Background: Homozygous familial hypercholesterolemia (HoFH) is a rare and devastating genetic condition characterized by extremely elevated levels of low-density lipoprotein cholesterol (LDL-C) leading to an increased risk of premature atherosclerosis ...
Meral Kayikcioglu, Hasan Selcuk Ozkan, Burcu Yagmur, Selen Bayraktaroglu, Asli Tetik Vardarli   +4 more
doaj   +1 more source